Oxf Med Case Reports 2018 Jan 9;2018(1):omx080. Epub 2018 Jan 9.
Division of Cardiology, Department of Internal Medicine, The George Washington University, Washington, DC 20037, USA.
Approved in 1989 for the management of treatment-resistant schizophrenia, Clozapine is a last-line atypical antipsychotic drug used with increasing frequency. In addition to its well-known side effect of agranulocytosis, this drug also carries with it rare but serious adverse cardiovascular risk of myocarditis. We present a patient on Clozapine who was admitted to the cardiology service with chest pain, ST segment elevations and elevated troponin concerning for acute myocardial infarction. Read More